Last updated: 25th December, 2019 December 22, 2015: FDA has approved AstraZeneca’s (AZN) new drug for Gout named Zurampic, but requires AstraZeneca to conduct a post-marketing study on its effect on kidneys and cardiovascular systems. The drug would also need to have a boxed warning about the risks of Kidney failure. What is Gout? Gout is a […]